AstraZeneca’s SAPHNELO ® (anifrolumab-fnia) has been approved in the US for self-administration as a once-weekly autoinjector ...
AstraZeneca's Saphnelo (anifrolumab) has been approved in the US for self-administration as a once-weekly autoinjector, the Saphnelo Pen, for the ...
From rental assistance to toiletries, the fund responds to struggling families’ requests in real time, filling gaps that fuel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results